MK-1167

MK-1167 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for MK-1167, covering 2024-10-03 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010) [Phase 1]